PATIENTS WITH HEAVILY PRETREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) WHO RESPOND TO ORAL SELINEXOR THERAPY SHOW PROLONGED SURVIVAL: UDPATED PHASE 1 RESULTS
Author(s):
John Kuruvilla
,
Morten Mau-Sørensen
,
Richard Stone
,
Nina Wagner-Johnston
,
Ramiro Garzon
,
Lynn Savoie
,
Ian Flinn
,
Rachid Baz
,
Michael Wang
,
Peter Martin
,
Nashat Gabrail
,
Peter Brown
,
Andre Goy
,
Tami Rashal
,
Robert Carlson
,
Yosef Landesman
,
Jean-Richard Saint-Martin
,
Tracey Marshall
,
Michael Savona
,
Sasha Norori
,
Sharon Shacham
,
Michael Kauffman
,
Martin Gutierrez